|
(5E)-5-({4-[(2,4-DICHLOROPHENYL)METHOXY]-3-ETHOXYPHENYL}METHYLIDENE)-1-(3,5-DIMETHYLPHENYL)-1,3-DIAZINANE-2,4,6-TRIONE |
|
Clostridium Streptococcus |
theta-toxin/PFO (Perfringolysin O) Pneumolysin |
Preclinical (in vitro) Preclinical (in vitro) |
Aziz UBA, et al. 2024. Nat Commun
|
|
(5E)-5-{[5-(2,4-dichlorophenyl)furan-2-yl]methylidene}-1-(3,5-dimethylphenyl)pyrimidine-2,4,6(1H,3H,5H)-trione |
Depiction based on curated SMILES
CH
3
O
N
H
O
Cl
Cl
O
CH
3
O
N
|
Clostridium Streptococcus |
theta-toxin/PFO (Perfringolysin O) Pneumolysin |
Preclinical (in vitro) Preclinical (in vitro) |
Aziz UBA, et al. 2024. Nat Commun
|
|
5-{3-[(2,4-difluorophenoxy)methyl]-4-methoxybenzylidene}-2,4,6(1H,3H,5H)-pyrimidinetrione |
Depiction based on curated SMILES
O
F
F
O
O
N
H
CH
3
HN
O
O
|
Clostridium Streptococcus |
theta-toxin/PFO (Perfringolysin O) Pneumolysin |
Preclinical (in vitro) Preclinical (in vitro) |
Aziz UBA, et al. 2024. Nat Commun
|
|
5-{4-[(2,4-dichlorobenzyl)oxy]-3-ethoxybenzylidene}pyrimidine-2,4,6(1H,3H,5H)-trione |
Depiction based on curated SMILES
Cl
Cl
O
O
NH
O
H
3
C
HN
O
O
|
Clostridium Streptococcus |
theta-toxin/PFO (Perfringolysin O) Pneumolysin |
Preclinical (in vitro) Preclinical (in vitro) |
Aziz UBA, et al. 2024. Nat Commun
|
|
2-(2-Pyridin-3-yl-vinyl)-3-m-tolyl-3H-quinazolin-4-one |
Depiction based on curated SMILES
N
O
H
3
C
N
N
|
Klebsiella |
Aerobactin |
Preclinical (in vitro) |
Bailey DC, et al. 2018. SLAS Discov |
|
2-(3-Pyridinyl)-3-(4-methoxyphenyl)-3,4-dihydroquinazoline-4-one |
Depiction based on curated SMILES
N
O
CH
3
N
N
O
|
Klebsiella |
Aerobactin |
Preclinical (in vitro) |
Bailey DC, et al. 2018. SLAS Discov |
|
3-(5-bromo-2-pyridyl)-2-(3-pyridyl)quinazolin-4-one |
Depiction based on curated SMILES
Br
N
N
N
N
O
|
Klebsiella |
Aerobactin |
Preclinical (in vitro) |
Bailey DC, et al. 2018. SLAS Discov |
|
N4-isobutyl-N2-((2-phenylthiazol-4-yl)methyl)pyrimidine-2,4-diamine |
Depiction based on curated SMILES
N
S
CH
3
N
H
N
N
N
H
H
3
C
|
Legionella |
Dot/Icm (Defect in organella trafficking/intracellular multiplication) |
Preclinical (in vitro) |
Cheng E, et al. 2022. mBio |
|
N-(2,5-dimethylphenyl)-2-(4-oxo-3(4H)-quinazolinyl)acetamide |
Depiction based on curated SMILES
O
N
N
CH
3
O
N
H
CH
3
|
Mycobacterium |
Immune modulation |
Preclinical (in vitro) |
Karanja CW, et al. 2021. ACS Infect Dis |
|
N-(2-methyl-5-nitrophenyl)-2-(4-oxoquinazolin-3(4H)-yl)acetamide |
Depiction based on curated SMILES
O
O
N
N
H
3
C
N
H
_
O
O
+
N
|
Mycobacterium |
Immune modulation |
Preclinical (in vitro) |
Karanja CW, et al. 2021. ACS Infect Dis |
|
| | |